Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2026 07:29 ET | Source: Research and Markets

Hepatic Impairment Market Analysis Report 2026-2036 Featuring AbbVie, Astellas Pharma, Gilead Sciences, F. Hoffmann La Roche, and Takeda Pharmaceuticals

Dublin, May 21, 2026 (GLOBE NEWSWIRE) -- The "Hepatic Impairment Market - A Global and Regional Analysis: Focus on Treatment, Disease Type, Country, 2026-2036" report has been added to ...
May 19, 2026 08:00 ET | Source: Novo Nordisk A/S

Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide

Novo Nordisk to unveil data showing semaglutide tackles the liver disease crisis affecting about 1 in 3 people living with overweight and obesity worldwide
May 18, 2026 11:34 ET | Source: Research and Markets

Hepatic Cirrhosis Market Research and Forecast Report 2026-2036, Profiles of Abbott, Astellas Pharma, Gilead Sciences, Novartis, Takeda Pharma, Grifols Therapeutics, and Cellaion

Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Hepatic Cirrhosis Market - A Global and Regional Analysis: Focus on Disease Type, Treatment, Country, 2026-2036" report has been added to ...
April 17, 2026 07:00 ET | Source: Yaqrit

Yaqrit Phase 2a data, clinical consensus boost YAQ007 and YAQ006 in Hepatic Encephalopathy

Newly published peer reviewed publications reinforce shift toward ammonia-directed treatment strategies in HE as rifaximin use comes under scrutiny
December 17, 2025 04:12 ET | Source: Research and Markets

Hepatology Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030

Dublin, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The "Hepatology Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's...
November 18, 2025 09:55 ET | Source: Research and Markets

Hepatorenal Syndrome Analysis and Forecast Report 2025-2035: Market Led by Mallinckrodt, Noorik, BioVie, and Ferring as Innovation, Partnerships, and Market Expansion Drive Competitive Growth

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Hepatorenal Syndrome Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 12, 2025 05:00 ET | Source: Yaqrit

First patient dosed in a proof-of-concept study of Yaqrit’s advanced microbiome therapeutic YAQ001 in patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease

Yaqrit progresses novel treatment into pilot study for primary sclerosing cholangitis and IBD. Results expected H2 2026
May 14, 2025 05:00 ET | Source: Yaqrit

Yaqrit strengthens funding and regulatory capability ahead of clinical trials with board and senior management team appointments

Yaqrit strengthens leadership team with leading biostatistician, an expert in liver trial design, and renowned US econ/finance strategist joining Board
April 28, 2025 11:27 ET | Source: Yaqrit

Yaqrit showcases clinical progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th

Yaqrit announces eight upcoming presentations at the EASL Congress showcasing progress for drugs and devices in late stage trials in advanced liver disease
March 21, 2025 06:00 ET | Source: Yaqrit

Yaqrit secures NIHR grant for pivotal trials of its liver support device, DIALIVE, for patients with liver failure

NIHR grant funds pivotal trial for Yaqrit's liver support device, DIALIVE, with potential to resolve life-threatening condition and impact survival.